Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology
/in Hyperthermia, International Publications, Malignant Lymphoma /von 1996-01-01 / Int J Hyperthermia 1996 Jan-Feb;12(1):3-20Hyperthermia–its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors
/in Glioblastoma, Hyperthermia, International Publications /von 1995-10-01 / Strahlenther Onkol 1995 Oct;171(10):560-72Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy
/in International Publications, Newcastle Disease Virus, Soft Tissue Sarcoma /von 1994-12-01 / Cancer Res. 1994 Dec;54(23):6017-21Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells
/in International Publications, Thyroid Cancer /von 1994-11-25 / Cancer Lett. 1994 Nov;87(1):65-71Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells
/in International Publications, Micronutrients /von 1994-04-01 / Biol Trace Elem Res 1994 Apr-May;41(1-2):115-27Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer
/in Hyperthermia, International Publications, Urothelial Carcinoma /von 1994-01-01 / Int J Hyperthermia 1994 Jan-Feb;10(1):31-40Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate
/in Hyperthermia, International Publications, Prostate Cancer /von 1993-05-20 / Int. J. Radiat. Oncol. Biol. Phys. 1993 May;26(2):253-9Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 1993-01-01 / Virchows Arch A Pathol Anat Histopathol 1993;422(5):351-5A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate
/in International Publications, Newcastle Disease Virus /von 1992-01-01 / Med Oncol Tumor Pharmacother 1992;9(4):169-71
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
- Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
- Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy